about
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate)...
Read More
23.97
-0.50
(-2.04%)
1.9M
XNAS Volume
High vol. this week
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Veracyte Inc is on 06 Aug 2025 for the purpose of Veracyte Inc Second Quarter Earnings Results for 2025
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Veracyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..